JP2006503017A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006503017A5 JP2006503017A5 JP2004532284A JP2004532284A JP2006503017A5 JP 2006503017 A5 JP2006503017 A5 JP 2006503017A5 JP 2004532284 A JP2004532284 A JP 2004532284A JP 2004532284 A JP2004532284 A JP 2004532284A JP 2006503017 A5 JP2006503017 A5 JP 2006503017A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- sequence
- immunogen
- immunogenic composition
- substitutions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0220212A GB0220212D0 (en) | 2002-08-30 | 2002-08-30 | Vaccine |
| GB0304672A GB0304672D0 (en) | 2003-02-28 | 2003-02-28 | Vaccines |
| PCT/GB2003/003703 WO2004019974A2 (en) | 2002-08-30 | 2003-08-28 | Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006503017A JP2006503017A (ja) | 2006-01-26 |
| JP2006503017A5 true JP2006503017A5 (https=) | 2006-06-15 |
Family
ID=31980003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004532284A Pending JP2006503017A (ja) | 2002-08-30 | 2003-08-28 | Ｉｌ−１３要素及びｔ細胞エピトープを含む免疫原組成物並びにその治療上の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060147417A1 (https=) |
| EP (1) | EP1532172A2 (https=) |
| JP (1) | JP2006503017A (https=) |
| AR (1) | AR041086A1 (https=) |
| AU (1) | AU2003259358A1 (https=) |
| CA (1) | CA2496409A1 (https=) |
| TW (1) | TW200407162A (https=) |
| WO (1) | WO2004019974A2 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006503018A (ja) * | 2002-08-30 | 2006-01-26 | グラクソ グループ リミテッド | ワクチン |
| SG10201404273QA (en) | 2003-12-23 | 2014-10-30 | Genentech Inc | Novel anti-il 13 antibodies and uses thereof |
| DE102004003572A1 (de) * | 2004-01-23 | 2005-08-18 | Bavarian Nordic A/S | Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens |
| KR100639397B1 (ko) * | 2004-03-18 | 2006-10-26 | (주)에스제이바이오메드 | 항비만용 면역원성 하이브리드 폴리펩타이드 및 이를포함하는 항비만 백신 조성물 |
| JP2008520684A (ja) | 2004-11-17 | 2008-06-19 | アブジェニックス・インコーポレーテッド | Ｉｌ−１３に対する完全ヒトモノクローナル抗体 |
| GB0615881D0 (en) * | 2006-08-10 | 2006-09-20 | Univ Southampton | Novel peptide for treatment of asthma |
| MX2009003188A (es) * | 2006-09-25 | 2009-05-22 | Sj Biomedic Inc | Polipeptidos hibridos inmunogenicos antiobesidad y composicion de vacuna antiobesidad que comprende los mismos. |
| AU2010269120B2 (en) * | 2009-07-06 | 2015-09-24 | The Australian National University | Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor |
| WO2015017034A1 (en) * | 2013-08-02 | 2015-02-05 | Gourdie Robert G | Methods of treating a cancer through targeted disruption of alpha connexin 43-zonula occludens-1 (zo-1) interaction |
| ES2915378T3 (es) | 2013-09-13 | 2022-06-22 | Hoffmann La Roche | Procedimientos para detectar y cuantificar una proteína de célula huésped en líneas celulares |
| EP4331605A3 (en) | 2013-09-13 | 2024-05-22 | F. Hoffmann-La Roche AG | Methods and compositions comprising purified recombinant polypeptides |
| WO2019061297A1 (zh) * | 2017-09-29 | 2019-04-04 | 苏州工业园区唯可达生物科技有限公司 | 一种cd4辅助性t细胞表位融合肽及其疫苗 |
| EP3574915A1 (en) | 2018-05-29 | 2019-12-04 | Neovacs | Immunogenic product comprising il-4 and/or il-13 for treating disorders associated with aberrant il-4 and/or il 13 expression or activity |
| BR112021012668A2 (pt) | 2018-12-28 | 2021-12-28 | United Biomedical Inc | Imunógenos de peptídeos que possuem como alvo interleucina 6 (il-6) e formulações dos mesmos para imunoterapia de doenças impactadas pela desregulação de il-6 |
| CN117222664A (zh) * | 2021-01-29 | 2023-12-12 | 拜耳动物保健有限责任公司 | 用于破坏自身耐受的疫苗组合物 |
| WO2023021195A1 (en) * | 2021-08-20 | 2023-02-23 | Neovacs | mRNA VACCINES COMPRISING IL-4 AND/OR IL-13 RNA AND USES THEREOF |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9717953D0 (en) * | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
| US6296843B1 (en) * | 1998-04-03 | 2001-10-02 | The Penn State Research Foundation | Mutagenized IL 13-based chimeric molecules |
| TR200103046T2 (tr) * | 1999-04-23 | 2002-06-21 | Pharmexa A/S | IL5 aktivitesini düşürmek için yöntem. |
| CA2404763A1 (en) * | 1999-11-11 | 2001-05-17 | Raj K. Puri | Mutated il-13 molecules and their uses |
| US6846486B1 (en) * | 2000-02-24 | 2005-01-25 | Advanced Biotherapy Concepts, Inc. | Method of treating allergy by administering an anti-histamine antibody |
| GB0105360D0 (en) * | 2001-03-03 | 2001-04-18 | Glaxo Group Ltd | Chimaeric immunogens |
-
2003
- 2003-08-28 JP JP2004532284A patent/JP2006503017A/ja active Pending
- 2003-08-28 US US10/526,060 patent/US20060147417A1/en not_active Abandoned
- 2003-08-28 AR ARP030103127A patent/AR041086A1/es not_active Application Discontinuation
- 2003-08-28 AU AU2003259358A patent/AU2003259358A1/en not_active Abandoned
- 2003-08-28 TW TW092123745A patent/TW200407162A/zh unknown
- 2003-08-28 CA CA002496409A patent/CA2496409A1/en not_active Abandoned
- 2003-08-28 EP EP03791019A patent/EP1532172A2/en not_active Withdrawn
- 2003-08-28 WO PCT/GB2003/003703 patent/WO2004019974A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006503017A5 (https=) | ||
| Theisen et al. | Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli | |
| CA1340472C (en) | Universal t-cell epitope derived from p. faciparum circumsporosoite protein | |
| EP1092774B1 (en) | Borrelia burgdorferi OspA polypeptide for immunization against Lyme disease | |
| AU637049B2 (en) | Recombinant flagellin vaccines | |
| PT1076662E (pt) | Proteínas transportadoras de poli-epítopos | |
| WO1992000055A1 (en) | Compositions and methods for the prevention and diagnosis of lyme disease | |
| RU2007146137A (ru) | Иммуногенные композиции на основе chlamydia trachomatis | |
| CA2565925C (en) | Vaccine for periodontal disease | |
| JP2005502314A5 (https=) | ||
| JPS6251994A (ja) | クロ−ン化抗原 | |
| JPH08509371A (ja) | ライム病の予防及び治療のためのＯｓｐＣ抗原ワクチンの免疫原性製剤及びかかる抗原の調製のための組換え方法 | |
| EP3029073B1 (en) | Polyvalent chimeric ospc vaccinogen and diagnostic antigen | |
| JP2006501249A5 (https=) | ||
| EP0638092A1 (en) | Synthetic peptide vaccines for dental caries | |
| JPH02291271A (ja) | 発現伝播体を有する組成物 | |
| US20190117756A1 (en) | Immunogenic Compositions and Vaccines Derived From Bacterial Surface Receptor Proteins | |
| JP3135060B2 (ja) | ヘモフィルスインフルエンザｂ型菌の外皮膜タンパク質Ｐ２の部分断片を用いた接合体 | |
| US12220453B2 (en) | Compositions and treatments for Haemophilus influenzae | |
| CN101880328A (zh) | 微小隐孢子虫Th多表位基因和融合蛋白及其应用 | |
| AU2001271124B2 (en) | Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis | |
| CN1187372C (zh) | 人绒毛膜促性腺激素基因工程合成嵌合肽及其制备方法 | |
| AU2001271124A1 (en) | Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis | |
| JPS63503197A (ja) | マラリアに対する保護免疫を与えるポリペプチド類 | |
| WO2002017960A1 (fr) | Vaccins contre $m(f)i$m(g)toxoplasma gondii$m(f)/i$m(g) |